Central obesity, defined as an enlarged white adipose tissue in the intra-abdominal area (visceral adipose tissue), is linked to metabolic risk, systemic low-grade inflammation, which is characterized by elevated C-reactive protein (CRP) levels and pro-inflammatory cytokines, insulin resistance (IR), and a higher risk of metabolic disorders prior to puberty [2, 27]. This evidence concerns the gene CRP and Insulin resistance.